MedTrace Logo

Effect of Green Tea Extract on Type 2 Diabetes

NCT00567905 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2009-01-13

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of green tea extract (GTE) on type 2 diabetes and to explore the relationship between GTE and related hormone peptides.

Conditions

Interventions

DIETARY_SUPPLEMENT

Green tea extract

main content is epigallocatechin gallate (EGCG, 58%)

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV

  • Taipei Hospital, Taiwan

    lead OTHER

Principal Investigators

  • Chung-Hua Hsu, MD; PhD · Branch of Chinese Medicine, Taipei City Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567905 on ClinicalTrials.gov